retatrutide and heart Data: What Surprised Cardiologists Substack Series 3 of 6:

Peptide Monthly Cost Analysis The following table summarizes the estimated monthly cost for each peptide during its active protocol period

This bundle provides the tools needed to stay on track and achieve your weight loss and metabolic health goals.*

Tens of thousands of gastrointestinal-related adverse events have been reported to the U.S

TRIUMPH-4, the first Phase 3 obesity readout (Dec 2025), reported about 28.7% mean weight loss at the top dose at 76 weeks the largest figure seen in any GLP-class trial so far

The heart as a whole was prepared and moved to a glass Petri dish filled with a modified Tyrodes solution, kept at room temperature